Literature DB >> 26200738

Molecular Characterization of the Human Immunodeficiency Virus Type 1 in Women and Their Vertically Infected Children.

Sara Nunes Vaz1,2, Marta Giovanetti2,3, Filipe Ferreira de Almeida Rego2, Tulio de Oliveira4, Siva Danaviah4, Maria Luiza Freire Gonçalves5, Luiz Carlos Junior Alcantara2, Carlos Brites1.   

Abstract

Approximately 35 million people worldwide are infected with human immunodeficiency virus (HIV) around 3.2 million of whom are children under 15 years. Mother-to-child-transmission (MTCT) of HIV-1 accounts for 90% of all infections in children. Despite great advances in the prevention of MTCT in Brazil, children are still becoming infected. Samples from 19 HIV-1-infected families were collected. DNA was extracted and fragments from gag, pol, and env were amplified and sequenced directly. Phylogenetic reconstruction was performed. Drug resistance analyses were performed in pol and env sequences. We found 82.1% of subtype B and 17.9% of BF recombinants. A prevalence of 43.9% drug resistance-associated mutations in pol sequences was identified. Of the drug-naive children 33.3% presented at least one mutation related to protease inhibitor/nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor (PI/NRTI/NNRTI) resistance. The prevalence of transmitted drug resistance mutations was 4.9%. On env we found a low prevalence of HR1 (4.9%) and HR2 (14.6%) mutations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26200738      PMCID: PMC4576942          DOI: 10.1089/AID.2015.0166

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

1.  Evaluation of primary resistance to HIV entry inhibitors among brazilian patients failing reverse transcriptase/protease inhibitors treatment reveal high prevalence of maraviroc resistance-related mutations.

Authors:  Cecília S Alencar; Anna S Nishiya; Suzete Ferreira; Maria Teresa M Giret; Ricardo S Diaz; Ester C Sabino
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-26       Impact factor: 2.205

2.  Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.

Authors:  Luciane Amorim Santos; Joana Paixao Monteiro-Cunha; Adriano Fernando Araujo; Carlos Brites; Bernardo Galvao-Castro; Luiz Carlos Junior Alcantara
Journal:  J Med Virol       Date:  2011-12       Impact factor: 2.327

3.  Transmitted Drug Resistance Among Recently Diagnosed Adults and Children in São Paulo, Brazil.

Authors:  Paula Morena de Souza Guimarães; João Leandro de Paula Ferreira; Luana Portes Ozório Coelho; Jaqueline de Souza Cavalcanti; Giselle Ibette Silva Lopez Lopes; Elaine Monteiro Matsuda; Flávia Jacqueline Almeida; Valéria Correia Almeida; Alexandre Ely Campeas; Luiz Carlos Pereira Junior; Luís Fernando de Macedo Brígido
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-04       Impact factor: 2.205

4.  HIV type 1 molecular epidemiology in pol and gp41 genes among naive patients from Mato Grosso do Sul State, central western Brazil.

Authors:  Alexsander Augusto da Silveira; Ludimila Paula Vaz Cardoso; Roberta Barbosa Lopes Francisco; Mariane Martins de Araújo Stefani
Journal:  AIDS Res Hum Retroviruses       Date:  2011-07-26       Impact factor: 2.205

5.  Lack of high-level resistance mutations in HIV type 1 BF recombinant strains circulating in northeast Brazil.

Authors:  Joana Paixao Monteiro-Cunha; Adriano Fernando Araujo; Edson Santos; Bernardo Galvao-Castro; Luiz Carlos Junior Alcantara
Journal:  AIDS Res Hum Retroviruses       Date:  2011-01-15       Impact factor: 2.205

6.  Lower prevalence of human immunodeficiency virus type 1 Brazilian subtype B found in northeastern Brazil with slower progression to AIDS.

Authors:  Adriano Fernando Araujo; Carlos Brites; Joana Monteiro-Cunha; Luciane Amorim Santos; Bernardo Galvao-Castro; Luiz Carlos Junior Alcantara
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09-21       Impact factor: 2.205

7.  2014 Update of the drug resistance mutations in HIV-1.

Authors:  Annemarie M Wensing; Vincent Calvez; Huldrych F Günthard; Victoria A Johnson; Roger Paredes; Deenan Pillay; Robert W Shafer; Douglas D Richman
Journal:  Top Antivir Med       Date:  2014 Jun-Jul

8.  Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.

Authors:  Mônica Nogueira da Guarda Reis; Keila Correa de Alcântara; Ludimila Paula Vaz Cardoso; Mariane Martins Araújo Stefani
Journal:  J Med Virol       Date:  2013-09-13       Impact factor: 2.327

9.  Variability of HIV-1 genomes among children and adolescents from São Paulo, Brazil.

Authors:  Sabri Saeed Sanabani; Rodrigo Pessôa; Ana Carolina Soares de Oliveira; Vanessa Pouza Martinez; Maria Teresa Maidana Giret; Regina Célia de Menezes Succi; Karina Carvalho; Claudia Satiko Tomiyama; Douglas F Nixon; Ester Cerdeira Sabino; Esper Georges Kallas
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

10.  The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance.

Authors:  Robert J Gifford; Tommy F Liu; Soo-Yon Rhee; Mark Kiuchi; Stephane Hue; Deenan Pillay; Robert W Shafer
Journal:  Bioinformatics       Date:  2009-03-20       Impact factor: 6.937

View more
  2 in total

1.  HIV-1 Diversity and Drug Resistance in Treatment-Naïve Children and Adolescents from Rio de Janeiro, Brazil.

Authors:  Suwellen Sardinha Dias de Azevedo; Edson Delatorre; Cibele Marina Gaido; Carlos Silva-de-Jesus; Monick Lindenmeyer Guimarães; José Carlos Couto-Fernandez; Mariza G Morgado
Journal:  Viruses       Date:  2022-08-12       Impact factor: 5.818

2.  Virological suppression in children and adolescents is not influenced by genotyping, but depends on optimal adherence to antiretroviral therapy.

Authors:  Juliana Costa de Abreu; Sara Nunes Vaz; Eduardo Martins Netto; Carlos Brites
Journal:  Braz J Infect Dis       Date:  2017-02-27       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.